A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Efficacy of 3VM1001 Cream for the Treatment of Chronic Pain Caused by Osteoarthritis of the Knee: A Dose Ranging Study

Trial Profile

A Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety and Efficacy of 3VM1001 Cream for the Treatment of Chronic Pain Caused by Osteoarthritis of the Knee: A Dose Ranging Study

Completed
Phase of Trial: Phase I/II

Latest Information Update: 16 Jul 2018

At a glance

  • Drugs 3VM 1001 (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors CDA Research Group
  • Most Recent Events

    • 04 Apr 2018 Status changed from recruiting to completed.
    • 29 Dec 2017 Planned primary completion date changed from 30 Oct 2017 to 30 Jan 2018.
    • 10 May 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top